Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
22
|
pubmed:dateCreated |
1979-7-25
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0025-8512
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
868-72
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:440075-Cephalosporins,
pubmed-meshheading:440075-Creatinine,
pubmed-meshheading:440075-Female,
pubmed-meshheading:440075-Humans,
pubmed-meshheading:440075-Kidney,
pubmed-meshheading:440075-Kidney Diseases,
pubmed-meshheading:440075-Male,
pubmed-meshheading:440075-Metabolic Clearance Rate
|
pubmed:year |
1979
|
pubmed:articleTitle |
[Pharmacokinetics of Cefazedon, a new cephalosporin antibiotic, in patients with normal and reduced kidney function].
|
pubmed:publicationType |
Journal Article
|